Facing sliding demand for its hepatitis C blockbuster drug, Big Pharma company Gilead is pushing for all Boomers to undergo testing for the disease. The firm sees a big profit opportunity in the notoriously unhealthy generation that has brought higher rates of disease into old age brackets.
© 2025 Hedgeye Risk Management, LLC
Substack is the home for great culture